You are not going to believe it. The bacteria living in your baby's gut play a major role in how well their vaccines work. Not the brand. Not the dose. The bacteria. A 2025 landmark study in Nature confirmed what researchers have suspected for years: the billions of friendly bacteria in your baby's intestines are playing a major role in whether a vaccine actually does its job.
The key player is called Bifidobacterium, a group of friendly bacteria that set up house in your baby's intestines in the very first weeks of life. They break down food, produce compounds that train the immune system, and act as a kind of coach for the immune cells, showing them what to pay attention to. By the time a vaccine arrives, the immune cells that have been coached by Bifidobacterium already know what to do with it. (If you've read Baby's First Ecosystem, you've already met these bacteria. This is what they've been building towards.)
Based on Ryan et al. (2025): the microbiota-immune-vaccine connection in infants
Breast milk contains a class of specialised carbohydrates called Human Milk Oligosaccharides (HMOs). Your baby cannot digest them. They exist in breast milk for one reason: to feed Bifidobacterium. Your body is packing lunch for the bacteria inside your baby, every single feed. (If you have read Baby's First Ecosystem, you have already met these sugars. This is what they have been building towards.)
In controlled studies, supplementing babies who had lost their Bifidobacterium directly improved their vaccine responses. The bacteria act as a direct lever on the immune system. Feed them, and the system works better.
The difference in Bifidobacterium dominance between breastfed and non-breastfed babies shows up as early as the first month of life. In countries where breastfeeding is the norm, Bifidobacterium dominates your baby's gut. Where breastfeeding stops earlier, levels drop.
Researchers followed 191 healthy babies from birth to 15 months, measuring their gut bacteria and their antibody levels after vaccinations. Babies who had received antibiotics in their first weeks of life had significantly lower antibody levels at both 7 months and 15 months. The antibiotics had wiped out a chunk of their Bifidobacterium population. With fewer of those bacteria present when the vaccine arrived, the immune response that followed was weaker.
Based on research on HMOs and Bifidobacterium colonization: the global breastfeeding difference
For babies on formula, some modern formulas now include added HMOs or prebiotic compounds designed to support Bifidobacterium growth. The research in this area is still evolving, and it is worth knowing that formula manufacturers are actively working on closing this gap.
If you are breastfeeding, you are already doing the thing. Your milk is actively building your baby's immune system through the bacteria it feeds. The HMOs are working in the background, right now, while you read this.
If antibiotics were necessary early on, this is recoverable. One course of neonatal antibiotics means Bifidobacterium has some recolonising to do. If you're breastfeeding afterwards, the HMOs in your milk actively support that recovery. Continued breastfeeding builds it back, week by week.
If you are doing a mix of breastmilk and formula, every feed of breastmilk counts. Research shows that mixed-fed babies carry Bifidobacterium levels between those of exclusively breastfed and formula-fed babies. The HMOs in your milk are still feeding those bacteria every time, even when formula is part of the routine.
If you are formula-feeding or have questions about your baby's gut health, talk to your paediatrician. Every baby is different, and your doctor can help you understand what's relevant for yours.
It is amazing to know how complex a role breastmilk plays in your child's development, including how they respond to vaccinations. Pretty cool, isn't it.
Join the conversation
Thoughts, questions, or research you've come across? Drop them below.